To evaluate the Safety and efficacy of Unani formulation Majoon Supari paak in SayalÄ?n al-Rahim (Leucorrhoea)
Phase 2
- Conditions
- Health Condition 1: N898- Other specified noninflammatory disorders of vagina
- Registration Number
- CTRI/2015/10/006290
- Lead Sponsor
- Central Council for Research in Unani Medicine New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 300
Inclusion Criteria
•Female patients in the age group of 13-45 years.
•Patients having excessive white discharge with or without any of the following associated symptoms
•Wajaâ?? al-Zahr (Backache)
•Naqahat (General Weakness)
•Faqr al-Dam (Anaemia) (8-10 mg % in females)
Exclusion Criteria
•Patients having acute/ acute on chronic/Chronic PIDs (as per the CDC Diagnostic Criteria attached as an annexure-IV)
•Patients on long-term medications.
•Patients on Oral Contraceptives/IUDs.
•Patients taking hormonal therapy.
•Any abnormal condition on p/s Examination.
•Pregnant and lactating women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method improvement in the sign and symptoms of SayalÄ?n al-Rahim (Leucorrhoea)Timepoint: 4 weeks
- Secondary Outcome Measures
Name Time Method Hematological and biochemical assessments for safetyTimepoint: 4 weeks